61
TITLE: Advanced therapy medicinal products for rare diseases: State of play of incentives supporting development in Europe
AUTHORS: Andreas M Farkas; Segundo Mariz; Violeta Stoyanova Beninska; Patrick Celis; Spiros Vamvakas; Kristina Larsson; Bruno Sepodes;
PUBLISHED: 2017, SOURCE: Frontiers in Medicine, VOLUME: 4, ISSUE: MAY
INDEXED IN: Scopus CrossRef: 24
IN MY: ORCID
62
TITLE: Red Raspberry Phenols Inhibit Angiogenesis: A Morphological and Subcellular Analysis Upon Human Endothelial Cells. RASPBERRYPOLYPHENOLSInANGIOGENESIS  Full Text
AUTHORS: Sousa, M; Machado, V; Costa, R; E. Figueira; Sepodes, B; Barata, P; Ribeiro, L ; Soares, R ;
PUBLISHED: 2016, SOURCE: JOURNAL OF CELLULAR BIOCHEMISTRY, VOLUME: 117, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef: 13
IN MY: ORCID
63
TITLE: Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy  Full Text
AUTHORS: Volker Straub; Pavel Balabanov; Kate Bushby; Monica Ensini; Nathalie Goemans; Annamaria De Luca; Alejandra Pereda; Robert Hemmings; Giles Campion; Edward Kaye; Virginia Arechavala Gomeza; Aurelie Goyenvalle; Erik Niks; Olav Veldhuizen; Pat Furlong; Violeta Stoyanova Beninska; Matthew J Wood; Alex Johnson; Eugenio Mercuri; Francesco Muntoni; Bruno Sepodes; Manuel Haas; Elizabeth Vroom; Annemieke Aartsma Rus; ...More
PUBLISHED: 2016, SOURCE: LANCET NEUROLOGY, VOLUME: 15, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
64
TITLE: Regulatory watch: The orphan drug pipeline in Europe  Full Text
AUTHORS: Morel, T; Lhoir, A; Picavet, E; Mariz, S; Sepodes, B; Llinares, J; Cassiman, D;
PUBLISHED: 2016, SOURCE: Nature Reviews Drug Discovery, VOLUME: 15, ISSUE: 6
INDEXED IN: Scopus CrossRef
IN MY: ORCID
65
TITLE: The orphan drug pipeline in Europe
AUTHORS: Thomas Morel; Eline Picavet; Andre Lhoir; Jordi Llinares; Segundo Mariz; Bruno Sepodes; David Cassiman;
PUBLISHED: 2016, SOURCE: NATURE REVIEWS DRUG DISCOVERY, VOLUME: 15, ISSUE: 6
INDEXED IN: WOS
IN MY: ORCID
66
TITLE: Worldwide collaboration for orphan drug designation
AUTHORS: Segundo Mariz; James H Reese; Kerstin Westermark; Lesley Greene; Takahiro Goto; Tatsuro Hoshino; Jordi Llinares Garcia; Bruno Sepodes;
PUBLISHED: 2016, SOURCE: NATURE REVIEWS DRUG DISCOVERY, VOLUME: 15, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
68
TITLE: Worldwide collaboration for orphan drug designation (vol 15 , pg 440, 2016)  Full Text
AUTHORS: Mariz, S; Reese, JH; Westermark, K; Greene, L; Goto, T; Hoshino, T; Llinares Garcia, J; Sepodes, B;
PUBLISHED: 2016, SOURCE: NATURE REVIEWS DRUG DISCOVERY, VOLUME: 15, ISSUE: 8
INDEXED IN: WOS
IN MY: ORCID
69
TITLE: Regulation Of Orphan Medicinal Products In Europe: History Trends And Challenges  Full Text
AUTHORS: Sepodes, B;
PUBLISHED: 2016, SOURCE: Clinical Therapeutics, VOLUME: 38, ISSUE: 10
INDEXED IN: CrossRef: 1
IN MY: ORCID
70
TITLE: Erratum: Worldwide collaboration for orphan drug designation  Full Text
AUTHORS: Segundo Mariz; James H Reese; Kerstin Westermark; Lesley Greene; Takahiro Goto; Tatsuro Hoshino; Jordi Llinares-Garcia; Bruno Sepodes;
PUBLISHED: 2016, SOURCE: Nature Reviews Drug Discovery, VOLUME: 15, ISSUE: 8
INDEXED IN: CrossRef
IN MY: ORCID
Page 7 of 14. Total results: 133.